Compare NNNN & GABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NNNN | GABC |
|---|---|---|
| Founded | 2021 | 1910 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2025 | N/A |
| Metric | NNNN | GABC |
|---|---|---|
| Price | $34.00 | $40.14 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $45.50 |
| AVG Volume (30 Days) | 34.4K | ★ 142.7K |
| Earning Date | 04-28-2026 | 01-26-2026 |
| Dividend Yield | N/A | ★ 2.90% |
| EPS Growth | N/A | ★ 3.79 |
| EPS | 0.06 | ★ 2.87 |
| Revenue | $8,185,146.00 | ★ $312,775,000.00 |
| Revenue This Year | N/A | $47.67 |
| Revenue Next Year | N/A | $6.23 |
| P/E Ratio | $662.94 | ★ $13.89 |
| Revenue Growth | 21.95 | ★ 26.55 |
| 52 Week Low | $5.18 | $32.75 |
| 52 Week High | $55.65 | $43.20 |
| Indicator | NNNN | GABC |
|---|---|---|
| Relative Strength Index (RSI) | 54.45 | 49.13 |
| Support Level | $31.18 | $39.82 |
| Resistance Level | $35.55 | $41.65 |
| Average True Range (ATR) | 5.14 | 0.62 |
| MACD | 0.14 | -0.12 |
| Stochastic Oscillator | 37.79 | 29.84 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
German American Bancorp Inc is a bank holding company. The lines of business include Retail and commercial banking business which involves attracting deposits from the general public and using those funds to originate consumer, commercial and agricultural, commercial and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services which involve providing trust, investment advisory, brokerage and retirement planning services to customers. Insurance operations include the offering of a full range of personal and corporate property and casualty insurance products.